AU2003303051A8 - Cell death inhibitor - Google Patents
Cell death inhibitorInfo
- Publication number
- AU2003303051A8 AU2003303051A8 AU2003303051A AU2003303051A AU2003303051A8 AU 2003303051 A8 AU2003303051 A8 AU 2003303051A8 AU 2003303051 A AU2003303051 A AU 2003303051A AU 2003303051 A AU2003303051 A AU 2003303051A AU 2003303051 A8 AU2003303051 A8 AU 2003303051A8
- Authority
- AU
- Australia
- Prior art keywords
- cell death
- death inhibitor
- inhibitor
- cell
- death
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002-366637 | 2002-12-18 | ||
JP2002366637A JP2004196701A (en) | 2002-12-18 | 2002-12-18 | Cell death inhibitor |
PCT/JP2003/015412 WO2004054594A1 (en) | 2002-12-18 | 2003-12-02 | Cell death inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003303051A8 true AU2003303051A8 (en) | 2004-07-09 |
AU2003303051A1 AU2003303051A1 (en) | 2004-07-09 |
Family
ID=32588319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003303051A Abandoned AU2003303051A1 (en) | 2002-12-18 | 2003-12-02 | Cell death inhibitor |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2004196701A (en) |
AU (1) | AU2003303051A1 (en) |
WO (1) | WO2004054594A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007117014A (en) * | 2005-10-28 | 2007-05-17 | Nissan Chem Ind Ltd | Nutritive supplement for preventing rheumatoid arthritis |
JP5820127B2 (en) * | 2011-02-17 | 2015-11-24 | フォーデイズ株式会社 | Preventive / ameliorating agent for neurodegenerative diseases with amyloid fibril formation |
WO2014202834A1 (en) * | 2013-06-18 | 2014-12-24 | University Of Helsinki | Protamine in treatment of neuronal injuries |
KR20170001567A (en) | 2015-06-26 | 2017-01-04 | 주식회사 파마리서치프로덕트 | Composition comprising mixture of DNA fragments separated from fish's semen or testis for the prevention or treatment of ischemic colitis |
KR102234367B1 (en) * | 2020-09-07 | 2021-03-31 | 바이오메디팜 어업회사법인 주식회사 | Extraction Method of high purity Poly Deoxy Ribo Nucleotide from testicular and sperm of Salmonid fish |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH062677B2 (en) * | 1984-05-26 | 1994-01-12 | 日産化学工業株式会社 | Hematopoietic organ recovery promoter |
JPH0669953B2 (en) * | 1985-08-16 | 1994-09-07 | 日産化学工業株式会社 | Cerebrospinal system neurotrophic agent |
JPH0551325A (en) * | 1991-04-19 | 1993-03-02 | Morinaga Milk Ind Co Ltd | Agent for promoting production of nerve growth factor |
JPH08187059A (en) * | 1994-06-06 | 1996-07-23 | J One Prod Kk | Production of food of nucleic acid |
JPH08165246A (en) * | 1994-12-10 | 1996-06-25 | Nisshoku Corp | Physiological activity promoter and physiological activity promotive encapsulating agent |
JPH10215828A (en) * | 1997-02-04 | 1998-08-18 | Nisshin Oil Mills Ltd:The | Active oxygen seed elimination agent |
JPH10218781A (en) * | 1997-02-04 | 1998-08-18 | Nisshin Oil Mills Ltd:The | Regulator for physical condition |
JP2000169386A (en) * | 1998-12-10 | 2000-06-20 | Sarude Yakuhin Kk | Immune function-activating agent, and beverage or food therefor |
JP2001061484A (en) * | 1999-06-23 | 2001-03-13 | Sankyo Co Ltd | Polynucleotide with anti-apoptotic activity |
BR9917605A (en) * | 1999-08-12 | 2003-03-05 | Alexandr V Asafov | Plasma Substitute Composition |
JP3682241B2 (en) * | 2001-05-25 | 2005-08-10 | Ykk Ap株式会社 | Sash performance prediction method and sash performance prediction program |
JP2003235504A (en) * | 2002-02-13 | 2003-08-26 | Marino Forum 21 | Endurance-building drug |
JP3713553B2 (en) * | 2002-05-15 | 2005-11-09 | 福美 森重 | Cerebrospinal neurotrophic agent containing arginine and RNA |
-
2002
- 2002-12-18 JP JP2002366637A patent/JP2004196701A/en active Pending
-
2003
- 2003-12-02 AU AU2003303051A patent/AU2003303051A1/en not_active Abandoned
- 2003-12-02 WO PCT/JP2003/015412 patent/WO2004054594A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2004054594A1 (en) | 2004-07-01 |
AU2003303051A1 (en) | 2004-07-09 |
JP2004196701A (en) | 2004-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG25482A (en) | Inhibitors | |
PL373146A1 (en) | Pyridazinone-derivatives as pde4 inhibitors | |
EP1547486A4 (en) | Storage case | |
AU2003202263A1 (en) | Roh-kinase inhibitors | |
EP1551801A4 (en) | Novel gamma-lactams as beta-secretase inhibitors | |
EP1474093A4 (en) | Granzyme b inhibitors | |
EP1532133A4 (en) | Nf-:b inhibitors | |
AU2003233426A8 (en) | Corrosion inhibitor | |
AU2003230392A8 (en) | Beta-secretase inhibitors | |
GB0212891D0 (en) | Jewllery case | |
GB0206357D0 (en) | Cells | |
EP1500402A4 (en) | Cell death inhibitor | |
GB0213293D0 (en) | Firelighters | |
AU2003303051A8 (en) | Cell death inhibitor | |
AU2003242559A8 (en) | Alkylaminosiloxanes as corrosion inhibitors | |
GB0313998D0 (en) | Plant limit dextrinase inhibitor | |
GB0305202D0 (en) | Scale inhibitor | |
GB0317231D0 (en) | Tranquilliser darts | |
AU2003232362A8 (en) | 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors | |
GB0206309D0 (en) | Isolated cells | |
EP1574454A4 (en) | Case | |
GB0201183D0 (en) | Darts | |
GB0313995D0 (en) | Plant limit dextrinase inhibitor promoter | |
GB0226149D0 (en) | Inhibitors | |
GB0206031D0 (en) | Inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TH | Corrigenda |
Free format text: IN VOL 18, NO 32, PAGE(S) 8415 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME NISSAN CHEMICAL INDUSTRIES, LTD., APPLICATION NO. 2003303051, UNDER INID (71) CORRECT THE NAME TO READ NISSAN CHEMICAL INDUSTRIES, LTD.; NISSEI BIO CO., LTD. |
|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |